Publications by authors named "Thomas Wiegmann"

Claim this Profile
D
Decreased Mortality After Long-Term Treatment With Dipeptidyl Peptidase-4 Inhibitors: A Retrospective Study of U.S. Veterans With Type 2 Diabetes.
Elizabeth Ann Cristiano, John M Miles, Samuel Worsham, Peter S Wiegmann, Mukut Sharma, Thomas Wiegmann

Endocr Pract· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT).
Michael V Rocco, Kaycee M Sink, Laura C Lovato, Dawn F Wolfgram, Thomas B Wiegmann

Am J Kidney Dis· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Albuminuria and Estimated Glomerular Filtration Rate with Functional Performance Measures in Older Adults with Chronic Kidney Disease.
Dawn F Wolfgram, Katelyn Garcia, Greg Evans, Sara Zamanian, Rocky Tang, Thomas Wiegmann

Am J Nephrol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author response to lipid-lowering in African Americans in ALLHAT-optimism bias?
Karen L Margolis, Barry R Davis, Charles Baimbridge, Jerry O Ciocon, Aloysius B Cuyjet, Thomas B Wiegmann

J Clin Hypertens (Greenwich)· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).
Karen L Margolis, Barry R Davis, Charles Baimbridge, Jerry O Ciocon, Aloysius B Cuyjet, Thomas B Wiegmann

J Clin Hypertens (Greenwich)· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy.
David K Packham, Rory Wolfe, Anne T Reutens, Tomas Berl, Hiddo Lambers Heerspink, Thomas B Wiegmann

J Am Soc Nephrol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria.
Hiddo Lambers Heerspink, Tom Greene, Julia B Lewis, Itamar Raz, Richard D Rohde, Thomas B Wiegmann

Nephrol Dial Transplant· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chymase increases glomerular albumin permeability via protease-activated receptor-2.
Ram Sharma, Vidudala Prasad, Ellen T McCarthy, Virginia J Savin, Kottarappat N Dileepan, Thomas Wiegmann

Mol Cell Biochem· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.
Mahboob Rahman, Sara Pressel, Barry R Davis, Chuke Nwachuku, Jackson T Wright, Thomas Wiegmann

Ann Intern Med· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes.
Ram Sharma, Mukut Sharma, Sreenivas Reddy, Virginia J Savin, Abdul Mateen Nagaria, Thomas B Wiegmann

Front Biosci· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial.
Tomas Berl, Lawrence G Hunsicker, Julia B Lewis, Marc A Pfeffer, Jerome G Porush, Thomas B Wiegmann

J Am Soc Nephrol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Mahboob Rahman, Sara Pressel, Barry R Davis, Chuke Nwachuku, Jackson T Wright, Thomas Wiegmann

Arch Intern Med· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy.
Robert C Atkins, Esther M Briganti, Julia B Lewis, Lawrence G Hunsicker, Gregory Braden, Thomas B Wiegmann

Am J Kidney Dis· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of irbesartan, blood pressure control, and proteinuria on renal outcomes in the Irbesartan Diabetic Nephropathy Trial.
Lawrence G Hunsicker, Robert C Atkins, Julia B Lewis, Gregory Braden, Paul J Champion de Crespigny, Thomas B Wiegmann

Kidney Int Suppl· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study.
Joshua I Barzilay, Barry R Davis, Judy Bettencourt, Karen L Margolis, David C Goff, Thomas Wiegmann

J Clin Hypertens (Greenwich)· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy.
Tomas Berl, Lawrence G Hunsicker, Julia B Lewis, Marc A Pfeffer, Jerome G Porush, Thomas B Wiegmann

Ann Intern Med· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Misoprostol on Contrast-Induced Renal Dysfunction.
Lawrence Gurkowski, Margaret MacDougall, Thomas Wiegmann

Am J Ther· November 1995

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis